New

North America Brain Cancer Diagnostics Market

2021

North America Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025904 | No. of Pages: 151 | Category: Medical Device | Status: Published

Market Insights

North America Brain Cancer Diagnostics Market to Grow at a CAGR of 17.1% to reach US$ 911.0 million by 2028 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The brain cancer diagnostics market in North America is expected to grow from US$ 301.5 million in 2021 to US$ 911.0 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2021 to 2028.

According to the American Association of Neurological Surgeons, glioblastoma is the most common malignant brain and other CNS tumor, accounting for 47.7% of all cases. The incidence of glioblastoma is 3.21 per 100,000 people. Early detection of tumors often provides more treatment options. Advanced imaging technology can pinpoint the location of brain tumors. Diagnostic tools include magnetic resonance imaging (MRI) and computed tomography (CT or CAT scan). Intraoperative MRI can also be used to guide tissue biopsy and tumor resection during surgery. Magnetic resonance spectroscopy (MRS) is used to examine the chemical characteristics of tumors. Thus, the increase in the prevalence of brain cancer highly demands brain cancer diagnostic tools.

The COVID-19 pandemic has disrupted healthcare systems, leading to concerns about its subsequent impact on non-COVID disease conditions. Cancer diagnosis and treatment are time-sensitive and are likely to be significantly affected by these conditions. The activities of each cancer discipline have been adversely affected by the COVID-19 pandemic. In addition, childhood malignant brain tumors are characterized by rapid growth and require early diagnosis and appropriate treatment. Therefore, delaying or modifying treatment can compromise its effectiveness and reduce patient survival. Flores et al. reported that delayed diagnosis of brain tumors is correlated with a worse prognosis. A prolonged pre-diagnostic symptomatic interval has negative and severe consequences, such as death or serious brain damage following the increase in intracranial pressure. Due to the fear and pressure of SARS CoV2 infection, changes in the decision-making process of children with brain tumors may have a negative impact on their final outcome. Never have multidisciplinary tumor boards serve a crucial role during the current COVID-19 outbreak. All pediatric cases diagnosed with a new brain tumor should be discussed in the multidisciplinary tumor board to determine the best treatment plan for each child.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the brain cancer diagnostics market. The North America brain cancer diagnostics market is expected to grow at a good CAGR during the forecast period.

North America brain cancer diagnostics market

Get more information on this report :


North America Brain Cancer Diagnostics Market Segmentation

By Diagnostic Type

  • Imaging Test
    • MRI
    • CT Scan
    • PET
  • Biopsy
  • Molecular Testing
  • Lumbar Puncture
  • Others

By Cancer Type

  • Glioblastoma Multiforme
  • Astrocytomas
  • Ependymomas
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Country

  • North America
    • US
    • Canada
    • Mexico

Companies Mentioned

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. MDxHealth
  5. NantOmics
  6. Biocept, Inc.
  7. Koninklijke Philips N.V
  8. Canon Medical Systems
  9. Hitachi, Ltd.
  10. Neusoft Medical Systems

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 North America Brain Cancer Diagnostics Market – By Country

2. North America Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- North America PEST Analysis

4.3 Expert Opinion

5. North America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – North America Analysis

6.1 North America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.3 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2 US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1 US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.3.3 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.4 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.4 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2 Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.2.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.4.3 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.4 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.5.3 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.4 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Brain Cancer Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MDxHealth

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 NantOmics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Biocept, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Koninklijke Philips N.V.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Canon Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Hitachi, Ltd.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Neusoft Medical Systems

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms


LIST OF TABLES

Table 1. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 2. US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments in the Brain Cancer Diagnostics Market

Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15. Glossary of Terms, Brain Cancer Diagnostics Market


LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. North America Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - North America PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. North America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in North American Country Markets

Figure 33. Growth Strategies Done by the Companies in the Market, (%)

  1. Thermo Fisher Scientific Inc.
  2. Siemens Healthineers A
  3. GE Healthcare
  4. MDxHealth
  5. NantOmics
  6. Biocept, Inc.
  7. Koninklijke Philips N.V
  8. Canon Medical Systems
  9. Hitachi, Ltd.
  10. Neusoft Medical Systems
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America brain cancer diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025904
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.